Outcomes after pelvic fascia-sparing robot-assisted radical prostatectomy vs. standard robot-assisted radical prostatectomy

Sarah Kodres-O’Brien , Christopher Dall , Tamir Sholklapper , Keith Kowalczyk

Mini-invasive Surgery ›› 2025, Vol. 9 ›› Issue (1) : 23

PDF
Mini-invasive Surgery ›› 2025, Vol. 9 ›› Issue (1) :23 DOI: 10.20517/2574-1225.2024.121
Review

Outcomes after pelvic fascia-sparing robot-assisted radical prostatectomy vs. standard robot-assisted radical prostatectomy

Author information +
History +
PDF

Abstract

Urinary incontinence immediately following robotic-assisted laparoscopic radical prostatectomy can significantly impact quality of life. Pelvic fascia-sparing robotic-assisted radical prostatectomy (PFS-RARP) was first described in 2010 to improve urinary functional outcomes via further preservation of anterior pelvic fascial structures. In this article, we summarize the anatomic basis, origin, and outcomes of PFS-RARP compared to standard RARP (S-RARP), highlighting potential advantages in urinary continence and ongoing debate over oncologic efficacy.

Keywords

Robot-assisted prostatectomy / Retzius-sparing prostatectomy / pelvic fascia-sparing prostatectomy / urinary continence / sexual function / outcomes / prostate cancer

Cite this article

Download citation ▾
Sarah Kodres-O’Brien, Christopher Dall, Tamir Sholklapper, Keith Kowalczyk. Outcomes after pelvic fascia-sparing robot-assisted radical prostatectomy vs. standard robot-assisted radical prostatectomy. Mini-invasive Surgery, 2025, 9(1): 23 DOI:10.20517/2574-1225.2024.121

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

AUANews. Westerman ME. Robotic prostatectomy: a game-changer in prostate cancer treatment. 2024. Available from: https://auanews.net/issues/articles/2024/february-2024/robotics-robotic-prostatectomy-a-game-changer-in-prostate-cancer-treatment. [Last accessed on 11 Jul 2025]

[2]

Lane A, Metcalfe C, Young GJ, et al; ProtecT Study group. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. BJU Int. 2016;118:869-79. PMCID:PMC5113698

[3]

Hoffman KE,Zhao Z.Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer.JAMA2020;323:149-63 PMCID:PMC6990712

[4]

Shi Z.Laparoscopic vs. open surgery: a comparative analysis of wound infection rates and recovery outcomes.Int Wound J2024;21:e14474 PMCID:PMC10898397

[5]

De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review.Urol Int2014;93:373-83

[6]

Borregales LD,Tal O.'Trifecta' after radical prostatectomy: is there a standard definition?.BJU Int2013;112:60-7

[7]

Ficarra V,Rosen RC.Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy.Eur Urol2012;62:405-17

[8]

Galfano A,Sozzi F.Beyond the learning curve of the Retzius-sparing approach for robot-assisted laparoscopic radical prostatectomy: oncologic and functional results of the first 200 patients with ≥ 1 year of follow-up.Eur Urol2013;64:974-80

[9]

Davis M,Marhamati S,Kowalczyk KJ.Retzius-sparing robot-assisted robotic prostatectomy: past, present, and future.Urol Clin North Am2021;48:11-23

[10]

Kowalczyk KJ,O’Neill J.Impact of Retzius-sparing versus standard robotic-assisted radical prostatectomy on penile shortening, Peyronie’s disease, and inguinal hernia sequelae.Eur Urol Open Sci2020;22:17-22 PMCID:PMC8317841

[11]

Egan J,Carvalho FLF.Retzius-sparing robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise on oncologic efficacy: single-surgeon series and step-by-step guide.Eur Urol2021;79:839-57

[12]

Mulhall JP,Guillonneau B.Artery sparing radical prostatectomy - myth or reality?.J Urol2008;179:827-31

[13]

Droupy S,Giuliano F.Penile arteries in humans. Origin - distribution - variations.Surg Radiol Anat1997;19:161-7

[14]

Alsaid B,Diallo D.Division of autonomic nerves within the neurovascular bundles distally into corpora cavernosa and corpus spongiosum components: immunohistochemical confirmation with three-dimensional reconstruction.Eur Urol2011;59:902-9

[15]

de Carvalho PA,Guglielmetti GB.Retrograde release of the neurovascular bundle with preservation of dorsal venous complex during robot-assisted radical prostatectomy: optimizing functional outcomes.Eur Urol2020;77:628-35

[16]

Barakat B,Gauger U,Hadaschik B.Retzius sparing radical prostatectomy versus robot-assisted radical prostatectomy: which technique is more beneficial for prostate cancer patients (MASTER study)? A systematic review and meta-analysis.Eur Urol Focus2022;8:1060-71

[17]

Checcucci E,Fiori C.Retzius-sparing robot-assisted radical prostatectomy vs the standard approach: a systematic review and analysis of comparative outcomes.BJU Int2020;125:8-16

[18]

Porcaro AB,Sebben M.Linear extent of positive surgical margin impacts biochemical recurrence after robot-assisted radical prostatectomy in a high-volume center.J Robot Surg2020;14:663-75

[19]

Lee S,Jo JK.Prognostic value of focal positive surgical margins after radical prostatectomy.Clin Genitourin Cancer2016;14:e313-9

[20]

Grypari IM,Tzelepi V.Radical or not-so-radical prostatectomy: do surgical margins matter?.Cancers2021;14:13 PMCID:PMC8749855

[21]

Dall CP,Choudhury E.Long-term outcomes of pelvic-fascia sparing robotic-assisted radical prostatectomy versus standard technique: superior urinary function and quality of life without compromising oncologic efficacy in a single-surgeon series.Urol Oncol2024;42:67.e17-24

[22]

Dalela D,Prasad MA.A pragmatic randomized controlled trial examining the impact of the Retzius-sparing approach on early urinary continence recovery after robot-assisted radical prostatectomy.Eur Urol2017;72:677-85

[23]

Kadhim H,Tan WS.Retzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy.J Robot Surg2022;16:1419-26

[24]

Dell’oglio P,Longoni M.Retzius-sparing robot-assisted radical prostatectomy in high-risk prostate cancer patients: results from a large single institution series.Eur Urol Open Sci2022;38:69-78 PMCID:PMC8898917

[25]

O’Connor-Cordova MA,Sancen-Herrera JP.Surgical and functional outcomes of Retzius-sparing robotic-assisted radical prostatectomy versus conventional robotic-assisted radical prostatectomy in patients with biopsy-confirmed prostate cancer. Are outcomes worth it? Systematic review and meta-analysis.Prostate2023;83:1395-414

[26]

Olivero A,Piccinelli M.Retzius-sparing robotic radical prostatectomy for surgeons in the learning curve: a propensity score-matching analysis.Eur Urol Focus2021;7:772-8

[27]

Yee CH,Chiu PKF,Hou SSM.A propensity score-matching study on Retzius-sparing robotic-assisted radical prostatectomy: evidence of continence advantage on the early learning curve.Asian J Surg2022;45:1403-7

[28]

Wong D,Henning G,Kim E.Retzius sparing prostatectomy effect on symptomatic lymphocele rates.Urology2021;149:129-32

[29]

Tahra A,Sobay R,Kucuk E.Comparison of Retzius-sparing versus standard robot-assisted radical prostatectomy for prostate cancer.Actas Urol Esp2022;46:293-300

[30]

Deng W,Liu X.Transvesical Retzius-sparing versus standard robot-assisted radical prostatectomy: a retrospective propensity score-adjusted analysis.Front Oncol2021;11:687010 PMCID:PMC8165391

[31]

Stonier T,Davis J.Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) vs standard RARP: it’s time for critical appraisal.BJU Int2019;123:5-7

[32]

Chipman JJ, Sanda MG, Dunn RL, et al; PROST-QA Consortium. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol. 2014;191:638-45. PMCID:PMC5006995

[33]

Ficarra V,Ahlering TE.Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.Eur Urol2012;62:418-30

[34]

Menon M,Jamil M.Functional recovery, oncologic outcomes and postoperative complications after robot-assisted radical prostatectomy: an evidence-based analysis comparing the Retzius sparing and standard approaches.J Urol2018;199:1210-7

[35]

Umari P,Cahill D,Eden D.Retzius-sparing versus standard robot-assisted radical prostatectomy: a comparative prospective study of nearly 500 patients.J Urol2021;205:780-90

[36]

Gontero P,Bartoletti R.New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function.J Urol2007;178:602-7

[37]

Carlsson S,Johansson E,Akre O.Self-perceived penile shortening after radical prostatectomy.Int J Impot Res2012;24:179-84

[38]

Tal R,Teloken P,Nelson CJ.Peyronie’s disease following radical prostatectomy: incidence and predictors.J Sex Med2010;7:1254-61

[39]

Würnschimmel C.Orphaned side-effects after robot-assisted radical prostatectomy: is the Retzius-sparing approach superior to the standard approach or are the data just not mature enough?.Eur Urol Open Sci2021;23:34-5 PMCID:PMC8317779

[40]

Alder R,Rosenberg J.Incidence of inguinal hernia after radical prostatectomy: a systematic review and meta-analysis.J Urol2020;203:265-74

[41]

Wagaskar VG,Sobotka S.Hood technique for robotic radical prostatectomy-preserving periurethral anatomical structures in the space of Retzius and sparing the pouch of douglas, enabling early return of continence without compromising surgical margin rates.Eur Urol2021;80:213-21

[42]

Mount Sinai. Hood technique enables early return to continence following RARP. 2020. Available from: https://reports.mountsinai.org/article/hood-technique-enables-early-return-to-continence-following-rarp. [Last accessed on 11 Jul 2025]

[43]

ClinicalTrials.gov. Clinical trial of approaches to prostate cancer surgery (PARTIAL). 2025. Available from: https://www.clinicaltrials.gov/ct2/show/NCT05155501. [Last accessed on 11 Jul 2025]

PDF

138

Accesses

0

Citation

Detail

Sections
Recommended

/